ChinaDaily Briefs

China: Li Auto, Evergrande, Horizon Robotics, New Horizon Health, Hong Kong Hang Seng Index, Asia High Yield Bond Index, MTR Corp, JD.com Inc (ADR), Indika Energy, SJM Holdings and more

In today’s briefing:

  • HSI, HSCEI, HSTECH: March Rebalance Flows Post Capping
  • Evergrande Sells Off More Projects to Firms That Promise to Finish Them
  • Horizon Robotics – Riding on Partnerships and a Strong List of Backers
  • New Horizon Health (6606.HK) – Far from Complete Reversal
  • HSI Meeting Bear Target – A50 Bull Wedge Maturing
  • Macro; Rating Changes; New Issues; Talking Heads; Top Gainers and Losers
  • MTR Corp (66): Lower Traffic from Lockdown.
  • JD.com (JD) Pre-Earning: Expect High Growth, Solid Position in Direct Sales
  • Morning Views Asia: Indika Energy, Jingrui Holdings, Tata Motors ADR
  • SJM Holdings – Earnings Flash – FY 2021 Results – Lucror Analytics

HSI, HSCEI, HSTECH: March Rebalance Flows Post Capping

By Brian Freitas


Evergrande Sells Off More Projects to Firms That Promise to Finish Them

By Caixin Global

  • Debt-ridden China Evergrande Group has announced it will sell stakes in four unfinished real estate projects to two state-owned trust firms
  • The move shows the lengths Evergrande is willing to go to comply with government directives for developers to complete projects they have already started
  • Two Evergrande subsidiaries are selling their 10% and 9.87% stakes in two projects in the cities of Chongqing and Dongguan

Horizon Robotics – Riding on Partnerships and a Strong List of Backers

By Clarence Chu

  • Horizon Robotics is an artificial intelligence chips developer for automobiles, specifically smart vehicles, and robots. 
  • Its latest Series C funding round in late 2020-early 2021, raised a combined total of US$900m, led by Great Wall Motors, Hillhouse, Baillie Gifford, CATL, CPE, Yunfeng Capital and others.
  • There were news reports doing the rounds that the firm had aimed to look at a potential US listing, in a deal that could raise up to US$1bn.

New Horizon Health (6606.HK) – Far from Complete Reversal

By Xinyao (Criss) Wang

  • New Horizon Health (6606 HK) has made some improvements based on 2021 preliminary financial data. The newly launched UU Tube also enriches the product line. 
  • However, the industry is still at the early stage. In front of fierce competition, ColoClear’s bottleneck is obvious. The cheaper products (Pupu Tube, UU Tube) could have more market acceptance. 
  • Based on our analysis, our view is that the Company may rebound temporarily, but it is too early for a complete reversal.

HSI Meeting Bear Target – A50 Bull Wedge Maturing

By Thomas Schroeder

  • HSI has been a top short in Asia and nearing our 22,200 tactical target to reduce short exposure. A50 represents the perform long to build as the bull wedge matures.
  • HSI RSI nearing oversold level where a rally is expected. Intermediate cycle remains down to sell a rally attempt in March.
  • A50 15k and 15,350 barriers to clear. Failing would require re setting near lower wedge support.

Macro; Rating Changes; New Issues; Talking Heads; Top Gainers and Losers

By BondEvalue

US equity markets were mixed on Monday with the S&P Nasdaq ending 0.2% lower and Nasdaq ending 0.4% higher. Sectoral gains were led by Energy, up 2.6%. European markets were lower – DAX, CAC and FTSE were down 0.7%, 1.4% and 0.4%. US 10Y Treasury yields eased 5bp to 1.85%. Brazil’s Bovespa was closed on account of Carnival holidays. In the Middle East, UAE’s ADX was up 2.2% and Saudi TASI was up 1.4%. Asian markets have opened with a positive bias – Shanghai, STI and Nikkei are up 0.3%, 0.8%, 1.5% and HSI was down 0.1% respectively. US IG CDS spreads widened 1.4bp and HY spreads were 6.1bp wider. EU Main CDS spreads were 3.1bp wider and Crossover CDS spreads were a 12.8bp wider. Asia ex-Japan CDS spreads were 4bp wider.

MTR Corp (66): Lower Traffic from Lockdown.

By Henry Soediarko

  • Zero COVID policy calls for another lockdown in Hong Kong as the number of cases rises.
  • A reduction in the number of services will help to cushion the blow but may not help the overall grim prospect of the firm. 
  • Lower traffic is negative for MTR Corp (66 HK)transport revenue as well as the commercial business from the station which combined make up to 50% of total revenue.

JD.com (JD) Pre-Earning: Expect High Growth, Solid Position in Direct Sales

By Ming Lu

  • We believe revenue will grow by 23% YoY in 4Q21 and by 18% in 2022.
  • We believe JD is the most promising direct-sales e-commerce company in China.
  • However, short video apps have been taking advertising market share from e-commerce apps.

Morning Views Asia: Indika Energy, Jingrui Holdings, Tata Motors ADR

By Charles Macgregor

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


SJM Holdings – Earnings Flash – FY 2021 Results – Lucror Analytics

By Leonard Law, CFA

SJM Holdings’ FY 2021 results remained weak, in a continuation from the soft H1 numbers. The company continued to report sizeable negative EBITDA in contrast to peers (which are all likely to report small positive EBITDA for the year). Moreover, operating cash burn has persisted in the two months YTD.

Liquidity is weak, given SJM’s low cash balance and lack of RCF availability. Moreover, the company would need to refinance its loans due February 2023. SJM’s delay in obtaining new long-term facilities is disappointing in our view, and reflects negatively on management’s execution. Still, we believe the company would not face issues seeking extensions or an eventual refinancing of its loan facilities, especially since the loans are secured against SJM’s assets.


Before it’s here, it’s on Smartkarma